RIYADH, Saudi Arabia, May 02, 2024 (GLOBE NEWSWIRE) -- KFSH&RC tops the healthcare sector in the Kingdom of Saudi Arabia and the Middle East, recognizing it as the most valuable healthcare brand in these regions for the second year. According ...
Read MoreEDMONTON, Alberta, May 02, 2024 (GLOBE NEWSWIRE) -- Amii (Alberta Machine Intelligence Institute) is thrilled to welcome the global AI community to Edmonton, Alberta, Canada for Upper Bound , May 21-24. Billed as “not your average AI ...
Read MoreApril 30, 2024 Philips AI-enabled diagnostic and experiential technologies help put patients at ease while empowering staff with faster, high-quality scans and increased diagnostic confidence Amsterdam, the Netherlands, and Miami, US – ...
Read MoreOver 150 scientific sessions will be presented during the congress, focusing on advancements in environmental science, food allergies, innovations in immunotherapy, and pediatric allergies, among others. Precision medicine, AI, ...
Read MoreApril 29, 2024 First-quarter highlights Group sales amounted to EUR 4.1 billion, with comparable sales growth of 2.4% Comparable order intake -3.8%, mainly due to China USD 1.1 billion Respironics litigation settlement reached in the US ...
Read MoreVANCOUVER, BC , Aug. 8, 2022 /PRNewswire/ -- Ondine Biomedical Inc. (LON: OBI), has recruited the final patient to its nasal photodisinfection exploratory Phase 2 trial. The trial is evaluating how effectively Ondine's nasal ...
Read MoreA large international study of patients with non-small cell lung cancer tumors that are two centimeters or less found that sub lobar surgery was non-inferior to lobectomy, according to results presented today at the IASLC World Conference on Lung ...
Read MoreFrom Gravitas Ventures, Smallbox Entertainment Group, Eating You Alive, and the Purjes Foundation, a new feature-length documentary film to be released on August 30, 2022 , in select theaters and streaming platforms. Pre-sale orders can be taken ...
Read MoreNetworkNewsWire Editorial Coverage LONDON , Aug. 8, 2022 /PRNewswire/ -- Nearly half of all American adults suffer from hypertension (high blood pressure), often referred to as a silent killer. More than 114 million adults in this ...
Read MoreAn interim analysis of overall survival data from the IMpower010 trial showed an overall survival trend in favor of atezolizumab in the PD-L1 TC > 1% stage II-IIIA population (OS HR, 0.71 [95% CI: 0.49, 1.03]), but not in the all randomized ...
Read MoreRoundtable brought medical practitioners and young people together to discuss the deadly effects of tobacco use, organized by MASH Project Foundation with technical partner Vital Strategies Event included unveiling of new interactive ...
Read MoreTarcocimab tedromer (KSI-301) dosed every two months met the primary endpoint of non-inferior visual acuity gains compared to aflibercept dosed every month First anti-VEGF therapy to achieve non-inferiority in visual acuity gains while doubling ...
Read MorePatients with lung cancer who attended a lung cancer screening event and who then participated in a personalized smoking cessation study achieved smoking abstinence rates of more than 30 percent, according to research presented today at the IASLC ...
Read MoreHon'ble Prime Minister of India, Shri Narendra Modi, will inaugurate Amrita Hospital, Faridabad, on August 24, 2022. The 2,400-bed healthcare institution will be India's largest private sector hospital and opens under the auspices of the Mata ...
Read More--ASC61 is an in-house developed oral PD-L1 small molecule inhibitor prodrug that showed significant antitumor efficacy in preclinical studies as a single agent in multiple animal models --ASC61-A treatment induced secretion of IFN? in a ...
Read MoreGEMSTONE-301 study result was presented at IASLC 2022 World Conference on Lung Cancer. In addition, the leading Principal Investigator Professor Yi-Long Wu was invited to highlight key data in a press conference In the final progression-free ...
Read MoreSAN FRANCISCO and SUZHOU, China , Aug. 7, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the ...
Read MoreSubscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers